PACS Deadline: PACS Investors with Losses in Excess of $100K Have Opportunity to Lead PACS Group Inc. Securities Fraud Lawsuit

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PACS Group Inc. common stock during its IPO and subsequent securities offerings about a class action lawsuit with a lead plaintiff deadline of January 13, 2025 [1][2]. Group 1: Class Action Details - Investors who purchased PACS common stock during the IPO or between April 11, 2024, and November 5, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that PACS engaged in misleading practices, including submitting false Medicare claims that significantly inflated its operating and net income from 2020 to 2023 [5]. Group 2: Allegations Against PACS - The lawsuit alleges that PACS was involved in a scheme to bill for unnecessary therapies to Medicare and falsified documentation related to licensure and staffing [5]. - As a result of these actions, the positive statements made by PACS regarding its business operations were materially misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].